Abstract
Epigenetic clocks use CpG DNA methylation (DNAm) to estimate biologic age; acceleration is associated with diabetes mellitus (DM), heart disease, and shorter life. It is unknown if DNAm age is also related to cardiometabolic outcomes in pregnancy. AgeAccelGrim is a novel epigenetic clock that combines 7 DNAm components. We sought to determine if AgeAccelGrim is associated with obstetric metabolic syndrome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
